Background Persons with toxic gain-of-function variants in the gene encoding apolipoprotein
L1 (APOL1) are at greater risk for the development of rapidly progressive, proteinuric …

The therapeutic approach to childhood nephrotic syndrome is based on a series of studies
that began with an international collaborative effort sponsored by the International Study of …

Background B-cell anomalies play a role in the pathogenesis of membranous nephropathy.
B-cell depletion with rituximab may therefore be noninferior to treatment with cyclosporine for …

The 2012 Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline
on glomerulonephritis (GN) is intended to assist the practitioner caring for patients with GN. …

The Nephrotic Syndrome Study Network (NEPTUNE) is a North American multicenter
collaborative consortium established to develop a translational research infrastructure for …

The 2011 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline
for Glomerulonephritis (GN) aims to assist practitioners caring for adults and children with GN…

We evaluated the association between anthropometric measurements and death among
pediatric patients with end-stage renal disease (ESRD) using data from the Pediatric Growth …

This NIH-funded multicenter randomized study of focal segmental glomerulosclerosis (FSGS)
treatment compared the efficacy of a 12-month course of cyclosporine to a combination of …

Overexpression of soluble urokinase receptor (suPAR) causes pathology in animal models
similar to primary FSGS, and one recent study demonstrated elevated levels of serum suPAR …

Primary focal segmental glomerulosclerosis (FSGS) is a disease with poor prognosis and
high unmet therapeutic need. Here, we evaluated the safety and pharmacokinetics of single-…